Related Experiment Video
Updated: Jan 29, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species
Thomas Skamris1, Carlotta Marasini1, Kenneth L Madsen2
1Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
Abstract:
The presence of αSN fibrils indisputably associates with the development of synucleinopathies. However, while certain fibril morphologies have been linked to downstream pathological phenotypes, others appear less harmful, leading to the concept of fibril strains, originally described in relation to prion disease. Indeed, the presence of fibrils does not associate directly with neurotoxicity. Rather, it has been suggested that the toxic compounds are soluble amyloidogenic oligomers, potentially co-existing with fibrils. Here, combining synchrotron radiation circular dichroism, transmission electron microscopy and binding assays on native plasma membrane sheets, we reveal distinct biological and biophysical differences between initial and matured fibrils, transformed within the timespan of few days. Immature fibrils are reservoirs of membrane-binding species, which in response to even gentle experimental changes release into solution in a reversible manner. In contrast, mature fibrils, albeit macroscopically indistinguishable from their less mature counterparts, are structurally robust, shielding the solution from the membrane active soluble species. We thus show that particular biological activity resides transiently with the fibrillating sample, distinct for one, but not the other, spontaneously formed fibril polymorph. These results shed new light on the principles of fibril polymorphism with consequent impact on future design of assays and therapeutic development.
Insights
Alpha-synuclein (αSN) fibrils exist in different forms. Immature fibrils release toxic species, while mature fibrils are stable, impacting synucleinopathy development and therapeutic strategies.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Alpha-synuclein (αSN) fibrils are linked to synucleinopathies, but their direct correlation with neurotoxicity is debated.
- Fibril strains and soluble oligomers are hypothesized to mediate αSN's toxicity, not necessarily the fibrils themselves.
Purpose of the Study:
- To investigate the distinct biological and biophysical properties of immature versus mature αSN fibrils.
- To understand the role of fibril morphology and dynamics in the release of potentially toxic soluble species.
Main Methods:
- Synchrotron radiation circular dichroism spectroscopy.
- Transmission electron microscopy (TEM).
- Binding assays using native plasma membrane sheets.
Main Results:
- Immature αSN fibrils act as reservoirs for membrane-binding species, releasing them reversibly into solution.
- Mature αSN fibrils are structurally robust and sequester these soluble species, preventing their release.
- Distinct fibril polymorphs exhibit transient biological activity related to soluble species release.
Conclusions:
- Fibril polymorphism influences the release of membrane-active soluble species, differentiating fibril toxicity.
- The dynamic state of αSN fibrils, not just their morphology, is critical for biological activity.
- Findings impact the design of diagnostic assays and therapeutic strategies for synucleinopathies.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
What is a Species?
Veins as Blood Reservoirs
Keystone Species
Formation of Species

